No profile data available.
Evogene Ltd. (EVGN) is a non-energy raw materials company in the broad agricultural chemical production industry, based in Rehovot, Israel, with about 38 full-time employees.
It reported revenue of $3.85 million for fiscal year 2025, down 54.7% from fiscal year 2024, and net income of -$8.49 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $347,000, down 60.7% from a year before. Its largest business segment, Industrial Applications, brought in 61% of segment revenue in fiscal year 2025; Africa was the largest region with 53%. Its market capitalization was $6.04 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications.
Evogene reported $3.85 million in revenue for fiscal year 2025, down 54.7% from $8.51 million in fiscal year 2024. In Q2 2026 revenue was $347,000.
Industrial Applications, with $2.17 million or 61% of segment revenue in fiscal year 2025. Next: Agriculture (39%).
Africa: 53% of revenue by region in fiscal year 2025, followed by Europe (26%).
$6.04 million as of October 9, 2026.
Listed companies of a similar size in the same industry (broad agricultural chemical production) include Bioceres Crop Solutions Corp. (BIOX), Sustainable Green Team, Ltd. (SGTM), Origin Agritech Limited (SEED), SenesTech, Inc. (SNES).